source
- Lilly's retatrutide outperforms Ozempic in phase 3 trial, cutting blood sugar and weight moreEli Lilly tested its triple-G candidate retatrutide against Novo Nordisk's Ozempic (semaglutide) in an open-label phase 3 study involving about 1,300 adults with type 2 diabetes whose glucose was n…
- Oura and UC San Diego Health launch trial linking smart ring data to obesity treatment outcomesOura and UC San Diego Health have partnered on a multi-year clinical trial called SMART-BMI to explore how continuous data from the Oura Ring may reflect patient response to obesity therapies. The…